Application of Regularized Regressions to Identify Novel Predictors in Clinical Research

Ton J. Cleophas · Aeilko H. Zwinderman

2024年12月 · Springer Nature

电子书

273

页

评分和评价未经验证了解详情

关于此电子书

This textbook is an important novel menu for multiple variables regression entitled "regularized regression". It is a must have for identifying unidentified leading factors. Also, you get fitted parameters for your overfitted data. Finally, there is no more need for commonly misunderstood p-values. Instead, the regression coefficient, R-value, as reported from a regression line has been applied as the key predictive estimator of the regression study. With simple one by one variable regression it is no wider than -1 to +1. With multiple variables regression it can easily get > +1 or -1. This means we have a seriously flawed regression model, mostly due to collinearity or non-linear data. Completing the analysis will lead to overfitting, and thus a meaningless significant study due to data spread wider than compatible with random. In order for the regression coefficients to remain in the right size, fortunately a shrinking procedure has been invented.In the past two decades regularized regression has become a major topic of research, particularly with high dimensional data. Yet, the method is pretty new and infrequently used in real-data analysis. Its performance as compared to traditional null hypothesis testing has to be confirmed by prospective comparisons. Most studies published to date are of a theoretical nature involving statistical modeling and simulation studies. The journals Nature and Science published 19 and 10 papers of this sort in the past 8 years. The current edition will for the first time systematically test regularized regression against traditional regression analysis in 20 clinical data examples.

The edition is also a textbook and tutorial for medical and healthcare students as well as recollection bench and help desk for professionals. Each chapter can be studied as a standalone, and, using, real as well as hypothesized data, it tests the performance of the novel methodology against traditional regressions. Step by step analyses of 20 data files are included for self-assessment. The authors are well qualified in their field. Professor Zwinderman is past-president of the International Society of Biostatistics and Professor Cleophas is past-president of the American College of Angiology. The authors have been working together for 25 years and their research can be characterized as a continued effort to demonstrate that clinical data analysis is a discipline at the interface of biology and mathematics.

作者简介

Ton J. Cleophas is internist-clinical pharmacologist at the Department of Medicine Albert Schweitzer Hospital Dordrecht the Netherlands. He is also professor of Statistics and member of the Scientific Committee of the European College of Pharmaceutical Medicine Lyon France. He is particularly interested in machine learning methodologies and published many complete-overview-textbooks of the subject.

Aeilko H. Zwinderman is professor of Statistics and Chair of the Department of Biostatistics and Epidemiology at the University of Amsterdam the Netherlands. His current work focuses on development and validation of multivariable models, particularly in genetic research, and he is a major developer of penalized canonical analysis.